304 related articles for article (PubMed ID: 28400627)
1. Molecular subtypes in cancers of the gastrointestinal tract.
Bijlsma MF; Sadanandam A; Tan P; Vermeulen L
Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):333-342. PubMed ID: 28400627
[TBL] [Abstract][Full Text] [Related]
2. Translating genomic profiling to gastrointestinal cancer treatment.
Harada K; Mizrak Kaya D; Shimodaira Y; Song S; Baba H; Ajani JA
Future Oncol; 2017 Apr; 13(10):919-934. PubMed ID: 28067073
[TBL] [Abstract][Full Text] [Related]
3. Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms.
Kidd M; Modlin I; Öberg K
Nat Rev Clin Oncol; 2016 Nov; 13(11):691-705. PubMed ID: 27273044
[TBL] [Abstract][Full Text] [Related]
4. The recurring features of molecular subtypes in distinct gastrointestinal malignancies-A systematic review.
Adam RS; Blomberg I; Ten Hoorn S; Bijlsma MF; Vermeulen L
Crit Rev Oncol Hematol; 2021 Aug; 164():103428. PubMed ID: 34284100
[TBL] [Abstract][Full Text] [Related]
5. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
[TBL] [Abstract][Full Text] [Related]
6. Management guidelines for gastrointestinal neuroendocrine neoplasm.
Kos-Kudła B
Endokrynol Pol; 2013; 64(6):V-VI. PubMed ID: 24575442
[No Abstract] [Full Text] [Related]
7. Targeted therapies and predictive markers in epithelial malignancies of the gastrointestinal tract.
McIntire M; Redston M
Arch Pathol Lab Med; 2012 May; 136(5):496-503. PubMed ID: 22229849
[TBL] [Abstract][Full Text] [Related]
8. Tumour biology and histopathology of neuroendocrine tumours.
Klöppel G
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):15-31. PubMed ID: 17382263
[TBL] [Abstract][Full Text] [Related]
9. [Pathological implications in the neuroendocrine gastrointestinal system].
Piette C; Polus M; Louis E
Rev Med Liege; 2002 Aug; 57(8):509-18. PubMed ID: 12405024
[TBL] [Abstract][Full Text] [Related]
10. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract][Full Text] [Related]
11. [Neuroendocrine tumors of the gastrointestinal tract].
Arnold C
Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
[TBL] [Abstract][Full Text] [Related]
12. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine tumour management: a team approach.
Banfield A; Green S; Ramage JK
Hosp Med; 2005 Jan; 66(1):37-42. PubMed ID: 15686165
[TBL] [Abstract][Full Text] [Related]
14. Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors.
Yan W; Zhang A; Powell MJ
Chin J Cancer; 2016 Jul; 35(1):68. PubMed ID: 27443349
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up.
Oberg K; Jelic S;
Ann Oncol; 2009 May; 20 Suppl 4():150-3. PubMed ID: 19454440
[No Abstract] [Full Text] [Related]
16. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.
Oberg K
Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940
[TBL] [Abstract][Full Text] [Related]
17. The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
Modlin IM; Kidd M; Bodei L; Drozdov I; Aslanian H
Am J Gastroenterol; 2015 Aug; 110(8):1223-32. PubMed ID: 26032155
[TBL] [Abstract][Full Text] [Related]
18. A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics.
Sadanandam A; Wullschleger S; Lyssiotis CA; Grötzinger C; Barbi S; Bersani S; Körner J; Wafy I; Mafficini A; Lawlor RT; Simbolo M; Asara JM; Bläker H; Cantley LC; Wiedenmann B; Scarpa A; Hanahan D
Cancer Discov; 2015 Dec; 5(12):1296-313. PubMed ID: 26446169
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic and therapeutic guidelines for gastrointestinal neuroendocrine tumors (recommended by the Polish Network of Neuroendocrine Tumors)].
Kos-Kudła B; Bolanowski M; Handkiewicz-Junak D; Jarzab B; Królicki L; Krzakowski M; Kunikowska J; Nasierowska-Guttmejer A; Nowak A; Rydzewska G; Starzyńska T; Szawłowski A;
Endokrynol Pol; 2008; 59(1):41-56. PubMed ID: 18335400
[TBL] [Abstract][Full Text] [Related]
20. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
